
1. medchemcomm. 2017 may 1;8(5):1069-1092. doi: 10.1039/c7md00052a. epub 2017 mar
15.

histone lysine methyltransferase structure activity relationships allow 
segregation g9a inhibition anti-plasmodium activity.

sundriyal s(1), chen pb(2)(3)(4), lubin as(1), lueg ga(1), li f(5), white ajp(1),
malmquist na(2)(3)(4), vedadi m(5)(6), scherf a(2)(3)(4), fuchter mj(1).

author information: 
(1)department chemistry , imperial college london , london sw7 2az , uk .
email: m.fuchter@imperial.ac.uk ; ; tel: +44 (0)2075945815.
(2)unité biologie des interactions hôte-parasite , département de parasites et
insectes vecteurs , institut pasteur , paris 75015 , france.
(3)cnrs erl 9195 , paris 75015 , france.
(4)inserm unit u1201 , paris 75015 , france.
(5)structural genomics consortium , university toronto , toronto , m5g 1l7 
, canada.
(6)department pharmacology toxicology , university toronto , toronto , 
on m5s 1a8 , canada.

plasmodium falciparum hkmts (pfhkmts) play key role controlling plasmodium
gene expression represent exciting new anti-malarial epigenetic targets.
using inhibitor series derived diaminoquinazoline hkmt inhibitory
chemotype, previously identified compounds highly promising
antimalarial activity, including irreversible asexual cycle blood
stage-independent cytotoxic activity nm concentrations, oral efficacy in
vivo models disease, unprecedented ability reactivate dormant liver
stage parasites (hypnozoites). however, future development series will
need address host versus parasite selectivity, inhibitory activity
against human g9a removed lead compounds, maintaining potent
anti-plasmodium activity. herein, report extensive study sar this
series g9a p. falciparum. identified key sar features
which demonstrate high parasite vs. g9a selectivity achieved by
selecting appropriate substituents position 2, 4 7 quinazoline
ring. also, turn, discovered potent g9a inhibitors be
identified employing 6-carbon 'nle mimic' position 7. together, data
suggests broadly similar, g9a potential pfhkmt target(s)
binding pockets and/or binding modes diaminoquinazoline analogues exhibit 
clear exploitable differences. based this, believe scaffold to
have clear potential development novel anti-malarial therapeutic.

doi: 10.1039/c7md00052a 
pmcid: pmc5708365
pmid: 29308121 

